Multiple myeloma in the elderly: Expert discussion

Novel targeting in acute myeloid leukaemia

Personalised medicine in Europe needs to be accessible to all

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody

Better understandings of gene mutations aid diagnostic tools in CLL

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL

Lenalidomide versus thalidomide in myeloma

Comment: Advances in haematological cancer presented at EHA 2014

Advances in mantle cell lymphoma: Expert discussion

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Genetically modified T cells fight haematological cancer